Screener
Lipocine LPCN Q4 2025 Annual earnings
Reported March 9, 2026 · Before market open
Revenue$1.1MBeat by $1.0M
EPS-$0.34Beat by $0.26
Revenue estimate$116.0K
EPS estimate-$0.60
Next report
Nov 5, 2026 (in a month)Revenue estimate$159.5K
EPS estimate-$0.39
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Lipocine report Q4 2025 earnings?
- Lipocine (LPCN) reported Q4 2025 earnings on March 9, 2026 before market open.
- What were Lipocine's Q4 2025 revenue and EPS?
- Lipocine reported revenue of $1.1M and eps of $-0.34 for Q4 2025.
- Did Lipocine beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $116.0K by $1.0M. EPS beat the consensus estimate of $-0.60 by $0.26.
- How did Lipocine's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 67.8% from $3.5M a year earlier.
- Where can I find Lipocine's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001493152-26-009428) and the 10-K periodic report (0001493152-26-009411) directly on SEC EDGAR. The filing index links above go to sec.gov.
